Bristol-Myers, UniQure To Team Up On Heart Disease

By | April 6, 2015

Scalper1 News

Bristol-Myers Squibb (BMY) announced Monday it acquired an initial equity stake in UniQure (QURE) as part of a partnership on gene therapies for heart disease. The drug giant is paying $33.83 per share for the stake, above Thursday’s closing price of $22.86, as well as an upfront payment of $50 million. Bristol-Myers will buy another 5% stake by the end of this year and be given warrants to buy up to another 10% stake in the company. The parties Scalper1 News

Scalper1 News